Chenxuan Zhu

Chenxuan Zhu

Auto-generated profile, based on publicly available information

Chenxuan Zhu

Affiliation School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CZChenxuan Zhu
Chenxuan Zhu
ZLZimeng Li
Zimeng Li
FLFanyu Lin
Fanyu Lin
LHLijuan Huang
Lijuan Huang
KCKeyao Cao
Keyao Cao
WLWei Li
Wei Li
Background: Since 2020, China has implemented DIP (Diagnosis-Intervention Packet) payment reform to control medical costs and reduce patient financial burden. The reform was piloted in a representative tertiary public hospital within a provincial DIP pilot city. Methods: The study used hospital settlement and medication records from January 2019 to June 2023. Interrupted time series analysis (ITSA) and structural change degree (SCD) were applied to evaluate the impact of DIP reform on weekly per capita costs and cost structures for surgical and non-surgical groups. Synergistic effects of health system reforms were also assessed. Results: From January 2019 to June 2023, total costs for surgical and non-surgical groups decreased by 3.42% and 1.25%, respectively. Drug and surgical costs declined significantly (p < 0.05) in both groups, while consumable costs increased significantly (p < 0.05). The growth rate of total costs slowed (surgical group: β 3 = −14.10; non-surgical group: β 3 = −10.76). Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β 1 + β 3 = −3.12). Drug costs (surgical group: β 3 = −5.50; non-surgical group: β 3 = −4.11) and inspection costs (surgical group: β 3 = −3.57; non-surgical group: β 3 = −1.73) decreased in both groups. Structural change analysis showed a degree of structural variation (DSV) of 10.34% for the surgical group and 5.60% for the non-surgical group. Contribution rates of structural variation (CSV) indicated significant contributions from consumable costs (CSV = 55.83%) and drug costs (CSV = 36.02%) in the surgical group, and inspection costs (CSV = 48.75%) in the non-surgical group. Conclusion: DIP payment reform led to positive outcomes in the cost structure of inpatient care. However, increases in inspection costs and differences in cost structures between groups need further attention. Future efforts should focus on more precise cost management.